참고문헌
- Leiting JL, Grotz TE. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World J Gastrointest Oncol 2018;10:282-289. https://doi.org/10.4251/wjgo.v10.i10.282
- Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 2014;134:622-628. https://doi.org/10.1002/ijc.28373
- Maeda H, Kobayashi M, Sakamoto J. Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol 2015;21:10936-10947. https://doi.org/10.3748/wjg.v21.i39.10936
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-233. https://doi.org/10.1016/j.cell.2009.01.002
- Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 2015;15:321-333. https://doi.org/10.1038/nrc3932
- Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-- the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011;8:467-477. https://doi.org/10.1038/nrclinonc.2011.76
- Ahadi M, Tehranian S, Memar B, Vossoughinia H, Salari M, Eskandari E, et al. Diagnostic value of carcinoembryonic antigen in malignancy-related ascites: systematic review and meta-analysis. Acta Gastroenterol Belg 2014;77:418-424.
- Han ES, Lee HH, Lee JS, Song KY, Park CH, Jeon HM. At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment. J Gastric Cancer 2014;14:123-128. https://doi.org/10.5230/jgc.2014.14.2.123
- Helwa I, Cai J, Drewry MD, Zimmerman A, Dinkins MB, Khaled ML, et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One 2017;12:e0170628. https://doi.org/10.1371/journal.pone.0170628
- Markowska A, Pendergrast RS, Pendergrast JS, Pendergrast PS. A novel method for the isolation of extracellular vesicles and RNA from urine. J Circ Biomark 2017;6:1849454417712666.
- Jamel S, Markar SR, Malietzis G, Acharya A, Athanasiou T, Hanna GB. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis. Gastric Cancer 2018;21:10-18. https://doi.org/10.1007/s10120-017-0749-y
- Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1-48. https://doi.org/10.5230/jgc.2019.19.e8
- Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R. miRNA profiling along tumour progression in ovarian carcinoma. J Cell Mol Med 2011;15:1593-1602. https://doi.org/10.1111/j.1582-4934.2010.01148.x
- Vaksman O, Trope C, Davidson B, Reich R. Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis 2014;35:2113-2120. https://doi.org/10.1093/carcin/bgu130
- Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya T, Yashiro M, Hirakawa K, et al. Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS One 2015;10:e0130472. https://doi.org/10.1371/journal.pone.0130472
- Yamamoto CM, Oakes ML, Murakami T, Muto MG, Berkowitz RS, Ng SW. Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers. J Ovarian Res 2018;11:20. https://doi.org/10.1186/s13048-018-0391-2
- Zavesky L, Jandakova E, Weinberger V, Minar L, Hanzikova V, Duskova D, et al. Ascites-derived extracellular microRNAs as potential biomarkers for ovarian cancer. Reprod Sci 2019;26:510-522. https://doi.org/10.1177/1933719118776808
- Schindler P, Kupcinskas J, Juzenas S, Skieceviciene J, Salteniene V, Schulz C, et al. Expression of microRNAs in the ascites of patients with peritoneal carcinomatosis and peritonitis. Cancer Cytopathol 2018;126:353-363. https://doi.org/10.1002/cncy.21966
- Kaleta EJ, Tolan NV, Ness KA, O'Kane D, Algeciras-Schimnich A. CEA, AFP and CA 19-9 analysis in peritoneal fluid to differentiate causes of ascites formation. Clin Biochem 2013;46:814-818. https://doi.org/10.1016/j.clinbiochem.2013.02.010
- Zhu FL, Ling AS, Wei Q, Ma J, Lu G. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites. Asian Pac J Cancer Prev 2015;16:719-722. https://doi.org/10.7314/APJCP.2015.16.2.719
- Chubb SP, Williams RA. Biochemical analysis of pleural fluid and ascites. Clin Biochem Rev 2018;39:39-50.
- Jung M, Jeung HC, Lee SS, Park JY, Hong S, Lee SH, et al. The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites. J Cancer Res Clin Oncol 2010;136:517-526. https://doi.org/10.1007/s00432-009-0684-3
- Song SE, Choi P, Kim JH, Jung K, Kim SE, Moon W, et al. Diagnostic value of carcinoembryonic antigen in ascites for colorectal cancer with peritoneal carcinomatosis. Korean J Gastroenterol 2018;71:332-337. https://doi.org/10.4166/kjg.2018.71.6.332
- Tian F, Shen Y, Chen Z, Li R, Lu J, Ge Q. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer. Gene 2016;591:338-343. https://doi.org/10.1016/j.gene.2016.06.014
- Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, et al. Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 2006;3:317-324.
- Ouyang M, Li Y, Ye S, Ma J, Lu L, Lv W, et al. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS One 2014;9:e96228. https://doi.org/10.1371/journal.pone.0096228
- Shi ZM, Wang XF, Qian X, Tao T, Wang L, Chen QD, et al. miRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. RNA 2013;19:552-560. https://doi.org/10.1261/rna.035972.112
- Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-146. https://doi.org/10.1016/S1470-2045(09)70343-2
- Jiang J, Zheng X, Xu X, Zhou Q, Yan H, Zhang X, et al. Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS One 2011;6:e23271. https://doi.org/10.1371/journal.pone.0023271
- Saito M, Okayama H, Saito K, Ando J, Kumamoto K, Nakamura I, et al. CDX2 is involved in microRNAassociated inflammatory carcinogenesis in gastric cancer. Oncol Lett 2017;14:6184-6190.
-
Zhou Q, Zheng X, Chen L, Xu B, Yang X, Jiang J, et al. Smad2/3/4 pathway contributes to
$TGF-{\beta}$ -induced miRNA-181b expression to promote gastric cancer metastasis by targeting Timp3. Cell Physiol Biochem 2016;39:453-466. https://doi.org/10.1159/000445638 - Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011;9:824-833. https://doi.org/10.1158/1541-7786.MCR-10-0529
- Huang S, Wang J, Li J, Luo Q, Zhao M, Zheng L, et al. Serum microRNA expression profile as a diagnostic panel for gastric cancer. Jpn J Clin Oncol 2016;46:811-818. https://doi.org/10.1093/jjco/hyw085
- Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X, et al. MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life 2012;64:628-635. https://doi.org/10.1002/iub.1030
- Li LQ, Yang Y, Chen H, Zhang L, Pan D, Xie WJ. MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene. Cancer Biomark 2016;17:75-81. https://doi.org/10.3233/CBM-160619
- Wang B, Li W, Guo K, Xiao Y, Wang Y, Fan J. miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochem Biophys Res Commun 2012;421:4-8. https://doi.org/10.1016/j.bbrc.2012.03.025
- Vuppalanchi R, Liang T, Goswami CP, Nalamasu R, Li L, Jones D, et al. Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis. PLoS One 2013;8:e74471. https://doi.org/10.1371/journal.pone.0074471
- Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, et al. Serum microRNA characterization identifies miR- 885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 2011;120:183-193. https://doi.org/10.1042/CS20100297
피인용 문헌
- Intercellular Communication by Vascular Endothelial Cell-Derived Extracellular Vesicles and Their MicroRNAs in Respiratory Diseases vol.7, 2019, https://doi.org/10.3389/fmolb.2020.619697
- Role of cell-free network communication in alcohol-associated disorders and liver metastasis vol.27, pp.41, 2019, https://doi.org/10.3748/wjg.v27.i41.7080
- The role and application of small extracellular vesicles in gastric cancer vol.20, pp.1, 2019, https://doi.org/10.1186/s12943-021-01365-z